180 related articles for article (PubMed ID: 25965948)
41. Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Kenny HA; Lal-Nag M; White EA; Shen M; Chiang CY; Mitra AK; Zhang Y; Curtis M; Schryver EM; Bettis S; Jadhav A; Boxer MB; Li Z; Ferrer M; Lengyel E
Nat Commun; 2015 Feb; 6():6220. PubMed ID: 25653139
[TBL] [Abstract][Full Text] [Related]
42. Morphology-based prediction of cancer cell migration using an artificial neural network and a random decision forest.
Zhang Z; Chen L; Humphries B; Brien R; Wicha MS; Luker KE; Luker GD; Chen YC; Yoon E
Integr Biol (Camb); 2018 Dec; 10(12):758-767. PubMed ID: 30420987
[TBL] [Abstract][Full Text] [Related]
43. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
[TBL] [Abstract][Full Text] [Related]
44. A high-throughput microfluidic single-cell screening platform capable of selective cell extraction.
Kim HS; Devarenne TP; Han A
Lab Chip; 2015 Jun; 15(11):2467-75. PubMed ID: 25939721
[TBL] [Abstract][Full Text] [Related]
45. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
[TBL] [Abstract][Full Text] [Related]
46. Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells.
Yang X; Li S; Li W; Chen J; Xiao X; Wang Y; Yan G; Chen L
Oncol Rep; 2013 Feb; 29(2):541-8. PubMed ID: 23165370
[TBL] [Abstract][Full Text] [Related]
47. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression.
Hung SP; Yang MH; Tseng KF; Lee OK
Cell Transplant; 2013; 22(10):1869-82. PubMed ID: 23067574
[TBL] [Abstract][Full Text] [Related]
49. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
50. Microfluidic co-culture system for cancer migratory analysis and anti-metastatic drugs screening.
Mi S; Du Z; Xu Y; Wu Z; Qian X; Zhang M; Sun W
Sci Rep; 2016 Oct; 6():35544. PubMed ID: 27762336
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
52. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
53. Concepts of metastasis in flux: the stromal progression model.
Sleeman JP; Christofori G; Fodde R; Collard JG; Berx G; Decraene C; Rüegg C
Semin Cancer Biol; 2012 Jun; 22(3):174-86. PubMed ID: 22374376
[TBL] [Abstract][Full Text] [Related]
54. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
55. Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition.
Wei SC; Yang J
Trends Cell Biol; 2016 Feb; 26(2):111-120. PubMed ID: 26508691
[TBL] [Abstract][Full Text] [Related]
56. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
Wei H; Li F; Fu P; Liu X
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):436-46. PubMed ID: 23467940
[TBL] [Abstract][Full Text] [Related]
57. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
58. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
59. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
[TBL] [Abstract][Full Text] [Related]
60. ElectroTaxis-on-a-Chip (ETC): an integrated quantitative high-throughput screening platform for electrical field-directed cell migration.
Zhao S; Zhu K; Zhang Y; Zhu Z; Xu Z; Zhao M; Pan T
Lab Chip; 2014 Nov; 14(22):4398-405. PubMed ID: 25242672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
